As BRCA1/2-mutated CRC tumors are more frequently of the mucinous adenocarcinoma subtype compared to BRCA1/2 wild-type tumors, this finding further suggests a role for the loss of BRCA1 activity in the development of mucinous adenocarcinoma [29]. This evidence concerns the gene BRCA1 and colorectal carcinoma.